Evidence map›Paper›PMID 37920359›Full record

ArticleChemical science2023

Ru(ii)/Os(ii)-based carbonic anhydrase inhibitors as photodynamic therapy photosensitizers for the treatment of hypoxic tumours.

Youchao Wang, Pierre Mesdom, Kallol Purkait, Bruno Saubaméa, Pierre Burckel, Philippe Arnoux, Céline Frochot, Kevin Cariou, Thibaud Rossel, Gilles Gasser

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Recent Advances in Anticancer Research of Osmium and Rhodium Complexes.Medicinal chemistry (Shariqah (United Arab Emirates)) · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Youchao WangChimie ParisTech, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, PSL University 75005 Paris France kevin.cariou@chimieparistech.psl.eu gilles.gasser@chimieparistech.psl.eu +33185784151 https://www.gassergroup.com.
Pierre MesdomChimie ParisTech, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, PSL University 75005 Paris France kevin.cariou@chimieparistech.psl.eu gilles.gasser@chimieparistech.psl.eu +33185784151 https://www.gassergroup.com.
Kallol PurkaitChimie ParisTech, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, PSL University 75005 Paris France kevin.cariou@chimieparistech.psl.eu gilles.gasser@chimieparistech.psl.eu +33185784151 https://www.gassergroup.com.
Bruno SaubaméaCellular and Molecular Imaging Facility, US25 Inserm, UAR3612 CNRS, Faculté de Pharmacie de Paris, Université Paris Cité F-75006 Paris France.
Pierre BurckelInstitut de Physique du Globe de Paris, Biogéochimie à; l'Anthropocène des Eléments et Contaminants Emergents 75005 Paris France.
Philippe ArnouxUniversité de Lorraine, CNRS, LRGP F-54000 Nancy France.
Céline FrochotUniversité de Lorraine, CNRS, LRGP F-54000 Nancy France.ORCID https://orcid.org/0000-0002-7659-3864
Kevin CariouChimie ParisTech, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, PSL University 75005 Paris France kevin.cariou@chimieparistech.psl.eu gilles.gasser@chimieparistech.psl.eu +33185784151 https://www.gassergroup.com.ORCID https://orcid.org/0000-0002-5854-9632
Thibaud RosselInstitute of Chemistry, University of Neuchâtel Avenue de Bellevaux 51 2000 Neuchâtel Switzerland thibaud.rossel@unine.ch.ORCID https://orcid.org/0000-0003-0254-5445
Gilles GasserChimie ParisTech, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, PSL University 75005 Paris France kevin.cariou@chimieparistech.psl.eu gilles.gasser@chimieparistech.psl.eu +33185784151 https://www.gassergroup.com.ORCID https://orcid.org/0000-0002-4244-5097
Centre National de la Recherche Scientifique · FRInstitut de physique du globe de Paris · FRUniversity of Neuchâtel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photodynamic therapy (PDT) is a medical technique for the treatment of cancer. It is based on the use of non-toxic molecules, called photosensitizers (PSs), that become toxic when irradiated with light and produce reactive oxygen specious (ROS) such as singlet oxygen (

Identifiers

PMID37920359
PMCPMC10619633
OpenAlexW4386972932

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.